Geron Corp.'s
compounds show promise in fighting HIV

Geron Corp. announced that research on two of its compounds have show that they help the body's own immune cells in fighting the production of viruses in HIV-infected cells. The compounds, small molecule telomerase activators named TAT0001 and TAT0002, enhanced the ability of CD8+ T cells to kill other HIV-infected immune cells, the research demonstrated. During the progression of HIV, CD8+ cells age faster than normal and lose their ability to kill off immune cells that have been infected with HIV. (AP)